Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

NCI to fund clinical trials of Pharmacyclics' Gd-Tex

Sep. 22, 1997

FDA panel recommends approval of Paxene

Sep. 22, 1997

Vaccine for colorectal cancer enters phase I/II

Sep. 22, 1997

Scotia signs licensing agreements for Foscan

Sep. 22, 1997

NCI sponsors trials of new treatment for MDR in multiple myeloma

Sep. 22, 1997

New antiapoptosis gene identified at Yale

Sep. 19, 1997

Advisory committee recommends approval of Photofrin for early-stage NSCLC

Sep. 19, 1997

Natural chemopreventive agent evaluated in rodent tumorigenesis models

Sep. 19, 1997

Oxford GlycoSciences' OGT-719 enters clinical testing

Sep. 18, 1997

3-D database search at Schering-Plough leads to potent, selective FPT inhibitors

Sep. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...